Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (5168)	8/17/1998 5:09:00 PM
From: Peter Singleton	Respond to of 6136

Steve, IMO, today's trading is a bear market rally. The big caps did better than the small caps ... take a look at the A/D and NH/NL. I don't think the market is making a judgement on AGPH per se. However, if we're in a bear market, how steep and how long it is will affect AGPH's stock price, even though I believe the company's fundamentals are likely to continue to improve. Peter

To: Steve Fancy who wrote (5168)	8/17/1998 6:36:00 PM
From: Vector1	Respond to of 6136

Steve, We have a different approach to investing. I buy on the fundementals and try not to worry about the technicals. Thats not to say I don't get discouraged when a stock like AGPH that IMO should be trading 10 points higher keeps slipping. It is a question of confidence in the fundamentals and the mettle to see it through. Very few fund managers are interested in buying small to mid cap biotechs. The small and mid cap funds are worried about redemptions and Asia and Russia have everyone concerned the big dow jump today notwithstanding. The flight to big caps is because these stocks have liquidity. Most of the big caps that went up today have much more exposure to Asia than AGPH. The HIV virus doesn't care about currency devaluations and the companies clinical results will stand on their own. V1